News items related to: News
-
100% Life, Initiativa Pozitivă, ITPC MENA, ATL MST-SIDA, and Salud por Derecho Filed Third-Party Observation at the European Patent Office Against Merck’s Patent Application on the HIV Prevention Pill Alimatravir (MK-8527)
In accordance with Article 115 of the European Patent Convention (EPC), following the publication of a European patent application, any...
-
New Report: Patent Monopolies, Single-Supplier Procurement and Volumes Fragmentation Are Driving Up HIV Medicine Costs
The 2021–2024 HIV Market Intelligence Report examines the procurement, pricing and regulatory environments for antiretroviral medicines in six countries: Argentina,...
-
Thai civil society urges protection of affordable medicines in Thailand-EU trade talks
On 17 September 2026, around 60 representatives of the coalition gathered at the Thai Parliament, where they met with members...
-
A pathway is not access: ITPC and MMA call for transparency on the Gilead–PAHO lenacapavir agreement
The agreement is particularly relevant for countries such as Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico,...
-
African Civil Society Groups Challenge Gilead’s Lenacapavir Prodrug Patent Application at ARIPO
ARIPO, a Harare-based intergovernmental intellectual property organisation grants and administers patents on behalf of states that are party to its...
-
Anti-Evergreening Safeguards Return to Indonesia’s Patent Law in Constitutional Court Victory for Patients’ Rights Group
The 2024 amendment was challenged by the Coalition for Patients’ Rights Advocacy for Access to Medicines. The Coalition comprises a...
-
Civil society groups in Argentina and Vietnam challenge patents on paediatric dolutegravir
Dolutegravir belongs to a class of antiretroviral medicines known as integrase inhibitors and is recommended by the World Health Organization...
-
Thai HIV Organization Challenges Patent Application to Safeguard Future Access to HIV Prevention Pill MK-8527
Merck’s investigational drug MK-8527 is being researched for HIV PrEP, with preclinical data showing the drug is an “attractive clinical...
-
Thailand, Ukraine, and Uzbekistan Fight Delamanid Monopolies in an Effort to Expand Affordable TB Treatment
MMA partner organizations in Uzbekistan, Thailand and Ukraine have filed patent oppositions against applications covering delamanid, an antibiotic used to...
-
New report documents Make Medicines Affordable campaign efforts to address patent barriers to bedaquiline for tuberculosis treatment
The case study focuses on advocacy and legal actions undertaken by civil society organizations in Brazil, Ukraine, Thailand, Belarus, India,...
-
From Kyiv to Rio: Activists Fight to Secure Affordable Prevention of and Treatment for Cervical Cancer
For cervical cancer prevention, the focus is on a patent application on a single-dose HPV vaccine. While a single-dose regimen...
-
New research highlights the importance of monitoring intellectual property rights in TB vaccine innovation
Frontiers in Public Health recently published research identifying potential challenges to accessing these vaccines. This important research, which increases the...